Tamoxifen as an antifertility agent in the long-tailed macaque (Macaca fascicularis).

Abstract:

:The potential use of tamoxifen, a nonsteroidal antiestrogen, as an antifertility agent was studied in the long-tailed macaque (Macaca fascicularis). Twenty-six cycling females were bred, then treated with a single oral dose of tamoxifen (5 mg/kg) (N = 13) or vehicle (N = 13) on day 4 post-ovulation. Serum progesterone (P4) and tamoxifen concentrations were evaluated on post-ovulation days 4, 8, 12, 16, and 18. No effects of treatment were observed on P4 concentrations or on the fertility rate--pregnancy was achieved in 4/13 controls (31%) and 6/13 treated females (46%). Analysis for serum tamoxifen concentrations in samples collected during the fertility and a supplemental pharmacokinetic study (N = 3; single oral dose of 10 mg/kg; urine and serum evaluated) failed to reveal any detectable tamoxifen levels. It was concluded that (1) absorption of tamoxifen may be negligible under the described treatment regimens or (2) tamoxifen metabolism/clearance occurs at a rapid rate.

journal_name

Contraception

journal_title

Contraception

authors

Tarantal AF,Hendrickx AG,Matlin SA,Lasley BL,Gu QQ,Thomas CA,Vince PM,Van Look PF

doi

10.1016/0010-7824(93)90047-b

subject

Has Abstract

pub_date

1993-03-01 00:00:00

pages

307-16

issue

3

eissn

0010-7824

issn

1879-0518

pii

0010-7824(93)90047-B

journal_volume

47

pub_type

杂志文章
  • A repeat dose of misoprostol 800 mcg following mifepristone for outpatient medical abortion at 64-70 and 71-77 days of gestation: A retrospective chart review.

    abstract:OBJECTIVE:To compare the effectiveness of outpatient medical abortion with mifepristone 200 mg and two misoprostol 800 mcg doses at 64-70 and 71-77 days of gestation. STUDY DESIGN:We conducted a retrospective chart review of medical abortion outcomes among clients with 64-77 day gestations at a Mexico City public clin...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2020.05.012

    authors: Dzuba IG,Castillo PW,Bousiéguez M,Lugo Hernández EM,Castañeda Vivar JJ,Sanhueza Smith P

    更新日期:2020-08-01 00:00:00

  • Developing future leaders in reproductive health through a scholarly concentration for medical students.

    abstract:OBJECTIVES:To evaluate the impact of a scholarly concentration for medical students, which aims to develop students' research, clinical and advocacy skills to promote women's reproductive health. STUDY DESIGN:Scholarly concentration programs provide opportunities to engage in scholarship beyond the traditional medical...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2014.07.005

    authors: Nothnagle M,Radlinski H,Magee SR,Allen RH

    更新日期:2014-11-01 00:00:00

  • The effect of levonorgestrel-releasing intrauterine device on menorrhagia in women taking anticoagulant medication after cardiac valve replacement.

    abstract:BACKGROUND:This study was conducted to evaluate the effect of levonorgestrel-releasing intrauterine devices (LNG-IUDs) on menorrhagia in patients receiving anticoagulant therapy after cardiac valve replacement. STUDY DESIGN:Forty women with menorrhagia who underwent cardiac valve replacement and were taking anticoagul...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2009.02.007

    authors: Kilic S,Yuksel B,Doganay M,Bardakci H,Akinsu F,Uzunlar O,Mollamahutoglu L

    更新日期:2009-08-01 00:00:00

  • Safety and efficacy of a triphasic oral contraceptive containing desogestrel: results of three multicenter trials.

    abstract::This report combines the data obtained in three multicenter efficacy studies with a new triphasic oral contraceptive combination containing desogestrel (DSG) and ethinyl estradiol (EE). The studies were conducted at 40 investigational sites in the United States (38 centers) and Canada (2 centers) in support of the FDA...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/0010-7824(93)90078-l

    authors: Darney P

    更新日期:1993-10-01 00:00:00

  • Inhibition of luteal phase progesterone levels in the rhesus monkey by epostane.

    abstract::This study examined the effect of epostane, a new antifertility drug, on normal and hCG-stimulated progesterone production during the luteal phase of the menstrual cycle in rhesus monkeys. When administered once each day for five days, epostane inhibited normal luteal phase progesterone levels in a dose-related fashio...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(85)90083-6

    authors: Snyder BW,Schane HP

    更新日期:1985-05-01 00:00:00

  • Results of a safety and feasibility study of the diaphragm used with ACIDFORM Gel or K-Y Jelly.

    abstract:BACKGROUND:New strategies are needed for preventing HIV infection in women. One potential approach is female-initiated use of an effective topical microbicidal gel in combination with a cervical barrier such as the diaphragm. STUDY DESIGN:Randomized, placebo-controlled safety and feasibility trial of diaphragm with va...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2009.10.011

    authors: von Mollendorf CE,Van Damme L,Moyes JA,Rees VH,Callahan MM,Mauck CK,Puren AJ,Tweedy K,Taylor D

    更新日期:2010-03-01 00:00:00

  • Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol.

    abstract::The pharmacokinetics and androgenic activity of Estrostep, a new oral contraceptive providing low-dose estrogen in a graduated sequence with a constant dose of progestin, were characterized in an open-label, nonrandomized study in 17 normally cycling women treated for three cycles with Estrostep. Women received 1 mg o...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章

    doi:10.1016/s0010-7824(01)00179-2

    authors: Boyd RA,Zegarac EA,Posvar EL,Flack MR

    更新日期:2001-02-01 00:00:00

  • Anti-implantation activity of luteal phase mifepristone administration is not mimicked by prostaglandin synthesis inhibitor or prostaglandin analogue in the rhesus monkey.

    abstract::The use of mifepristone as an anti-implantation agent in the primate has been explored in the rhesus monkey with two specific aims: (i) to determine the contraceptive efficacy of very low-dose mifepristone administered on mated cycle days 16, 17, and 18; and (ii) to test the hypothesis that alteration in endometrial p...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(96)00280-6

    authors: Nayak NR,Ghosh D,Lasley BL,Sengupta J

    更新日期:1997-02-01 00:00:00

  • Serium protein-bound carbohydrate and seromucoid levels during long-acting progestational contraceptive therapy.

    abstract::The effect of 2 long-acting injectables on the plasma protein-bound carbohydrate components and serumucoid when taken for different periods, was illustrated in 100 women of childbearing age. 40 acted as controls, 30 took depot-medroxyprogesterone acetate (DMPA), and 30 took norethisterone enanthate (NET-EN). DMPA wa...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章

    doi:10.1016/0010-7824(77)90051-8

    authors: Saleh FM

    更新日期:1977-10-01 00:00:00

  • A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.

    abstract::A randomised cross-over trial was performed to compare the pharmacodynamic actions of three low-dose oral contraceptives (OCs): Marvelon (150 micrograms desogestrel (DSG)+ 30 micrograms ethinyloestradiol (EE)), Mercilon (150 micrograms DSG + 20 micrograms EE) and Microgynon (150 micrograms levonorgestrel (LNG) + 30 mi...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(92)90103-z

    authors: Song S,Chen JK,Yang PJ,He ML,Li LM,Fan BC,Rekers H,Fotherby K

    更新日期:1992-06-01 00:00:00

  • Increasing access to safe abortion services in rural India: experiences with medical abortion in a primary health center.

    abstract:INTRODUCTION:To increase access to safe abortion in rural India, the feasibility and acceptability of mifepristone-misoprostol abortion was assessed in a typical government run primary health center (PHC) in Nagpur district, Maharashtra State, that does not offer surgical abortion services and must refer off-site for e...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2007.03.010

    authors: Mundle S,Elul B,Anand A,Kalyanwala S,Ughade S

    更新日期:2007-07-01 00:00:00

  • A new non-hormonal antifertility drug DL-204: I. Effects on testes and accessory glands of reproduction in male rats.

    abstract::The effect of DL-204, 2-(3-ethoxyphenyl)-5,6-dihydro-5-triazole (5,1a)-isoquinoline, a non-hormonal post-implantational anti-fertility drug, on tissue weights, nucleic acids and total protein concentrations in the testes, ventral prostate and seminal vesicles were evaluated in immature and sexually mature rats, while ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(87)90008-4

    authors: Prasad RS,Vijayan E

    更新日期:1987-11-01 00:00:00

  • Ethinyl estradiol-to-desogestrel ratio impacts endothelial function in young women.

    abstract:BACKGROUND:Ethinyl estradiol (EE) and progestins have the ability to alter endothelial function. The type of progestin and the ratio of EE to progestin used in oral contraceptive pills (OCPs) may determine how they affect the arterial vasculature. STUDY DESIGN:In this study, we investigated endothelial function across...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2008.07.025

    authors: Meendering JR,Torgrimson BN,Miller NP,Kaplan PF,Minson CT

    更新日期:2009-01-01 00:00:00

  • A pharmacokinetic and pharmacodynamic study of a 'visiting pill' containing norethisterone.

    abstract::The pharmacokinetics and pharmacodynamic effects of two doses of norethisterone (5mg and 3mg) used as a 'visiting pill' were investigated. There were no significant differences in the pharmacokinetics of the two doses except for the peak concentration achieved and the bioavailability as assessed by the area under the ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(86)90008-9

    authors: Song S,Chen JK,Yang PJ,Cheng DH,Liu WY,Fotherby K

    更新日期:1986-09-01 00:00:00

  • Controversies in family planning: intrauterine device placement in solid organ transplant patients.

    abstract::With an ever-increasing number of reproductive-aged women undergoing solid organ transplant and fertility improving after transplant, knowledge of the safety and efficacy of various contraceptive methods is essential to guide patient selection. We present the case of a 22-year-old patient desiring an intrauterine devi...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2019.05.012

    authors: Gordon C,Harken T

    更新日期:2019-09-01 00:00:00

  • Clarification of contraceptive drug pharmacokinetics in obesity.

    abstract::Related to concerns about the role of obesity in the efficacy of contraceptive drugs, a review of the literature was carried out in regard to the pharmacokinetics of ethinyl estradiol and various progestins given by various routes of administration. Most studies show that obese women exhibit modestly lower plasma conc...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2016.08.003

    authors: Jusko WJ

    更新日期:2017-01-01 00:00:00

  • Cervical preparation for second-trimester surgical abortion prior to 20 weeks' gestation: SFP Guideline #2013-4.

    abstract::For a dilation and evacuation (D&E) procedure, the cervix must be dilated sufficiently to allow passage of operative instruments and products of conception without injuring the uterus or cervical canal. Preoperative preparation of the cervix reduces the risk of cervical laceration and uterine perforation. The cervix m...

    journal_title:Contraception

    pub_type: 杂志文章,实务指引

    doi:10.1016/j.contraception.2013.11.001

    authors: Fox MC,Krajewski CM

    更新日期:2014-02-01 00:00:00

  • Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study.

    abstract:BACKGROUND:Hypertension is recognized as a major risk factor for coronary, cerebral and renal vascular disease. Hormonal methods of contraception may increase the risk for cardiovascular events. We evaluated whether the combined hormonal contraceptive vaginal ring that releases 15-mcg ethinylestradiol and 120 mcg of et...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2013.04.003

    authors: Cagnacci A,Zanin R,Napolitano A,Arangino S,Volpe A

    更新日期:2013-10-01 00:00:00

  • Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel.

    abstract::The metabolic and hemostatic effects of two oral contraceptives containing 150 mcg desogestrel and 20 mcg ethinyl-estradiol (EE) (MERCILON) or 30 mcg EE (MARVELON) were compared in order to examine the effect of reducing the EE dose in contraceptive pills. Forty-nine women participated in this randomized study during ...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(93)90141-s

    authors: Basdevant A,Conard J,Pelissier C,Guyene TT,Lapousterle C,Mayer M,Guy-Grand B,Degrelle H

    更新日期:1993-09-01 00:00:00

  • Pregnancy outcomes associated with extended use of the 52-mg 20 μg/day levonorgestrel-releasing intrauterine system beyond 60 months: A chart review of 776 women in Brazil.

    abstract:OBJECTIVE:To assess the contraceptive performance of the 52-mg 20 μg/day levonorgestrel-releasing intrauterine system (LNG-IUS, Mirena; Bayer Oy, Turku, Finland) among women who maintain the same device without changes after 60 months. STUDY DESIGN:This is a chart review study in which we assessed the charts of 766 wo...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2017.10.007

    authors: Bahamondes L,Fernandes A,Bahamondes MV,Juliato CT,Ali M,Monteiro I

    更新日期:2018-03-01 00:00:00

  • Interaction of condom design and user techniques and condom acceptability.

    abstract::In 1991, the source of public sector condom supplies in an African country changed from USAID to WHO. Following a complaint, the two types of condoms were sampled and compared. Laboratory tests indicated that the new-style condoms were of adequate quality, but a number of differences were noted between the two types. ...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/0010-7824(95)00183-b

    authors: Gerofi J,Deniaud F,Friel P

    更新日期:1995-10-01 00:00:00

  • Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, nonusers and discontinuers of hormonal contraception.

    abstract:BACKGROUND:Weight gain is commonly reported as a side effect of hormonal contraception and can lead to method discontinuation or reluctance to initiate the method. The purpose of this study was to investigate weight change in adolescent (aged 15-19 years) users of depot-medroxyprogesterone acetate (DMPA), norethisteron...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2009.07.007

    authors: Beksinska ME,Smit JA,Kleinschmidt I,Milford C,Farley TM

    更新日期:2010-01-01 00:00:00

  • Utility and drawbacks of continuous use of a copper T IUD for 20 years.

    abstract::This article examines interrelated questions concerning the extent of need for contraception in women 40 years and older and the degree to which that need can be served when use of collared T IUDs is initiated in women aged 25-35 years. Differentials in the impacts of intrauterine device (IUD) use on health issues in ...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2007.01.016

    authors: Sivin I

    更新日期:2007-06-01 00:00:00

  • Fertility considerations and attitudes about family planning among women with cystic fibrosis.

    abstract:OBJECTIVE:Our objective was to explore knowledge, attitudes and beliefs about pregnancy and contraceptive decision-making among reproductive-aged women with cystic fibrosis. STUDY DESIGN:In this qualitative study, we used purposive sampling of reproductive age women enrolled in the Adult Cystic Fibrosis program at Pen...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2019.05.005

    authors: Traxler SA,Chavez V,Hadjiliadis D,Shea JA,Mollen C,Schreiber CA

    更新日期:2019-09-01 00:00:00

  • Comparison of outcomes at 6 weeks following postpartum intrauterine contraceptive device insertions by doctors and nurses in India: a case-control study.

    abstract:OBJECTIVE:As part of a strategy to revitalize postpartum family planning services, Government of India revised its policy in 2013 to permit trained nurses and midwives to insert postpartum intrauterine contraceptive devices (PPIUCDs). This study compares two key outcomes of PPIUCD insertions--expulsion and infection--f...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2015.12.012

    authors: Yadav V,Balasubramaniam S,Das S,Srivastava A,Srivastava A,Kumar S,Sood B

    更新日期:2016-04-01 00:00:00

  • Continuation of copper-containing intrauterine devices at 6 months.

    abstract:BACKGROUND:Intrauterine devices (IUDs) are highly effective at preventing pregnancy and cost-effective. Suboptimal continuation of IUDs places women at risk of unintended pregnancy. Little is known about prevalence or predictors of discontinuation of IUDs within the first 6 months. STUDY DESIGN:A retrospective cohort ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2012.09.013

    authors: Garbers S,Haines-Stephan J,Lipton Y,Meserve A,Spieler L,Chiasson MA

    更新日期:2013-01-01 00:00:00

  • Rebound of medication abortion in Texas following updated mifepristone label.

    abstract:BACKGROUND:In 2013, Texas House Bill 2 (HB 2) placed restrictions on the use of medication abortion, which later were nullified with the 2016 FDA-approved mifepristone label. METHODS:Using data collected directly from Texas abortion facilities, we evaluated changes in the provision and use of medication abortion durin...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2019.01.001

    authors: Baum SE,White K,Hopkins K,Potter JE,Grossman D

    更新日期:2019-05-01 00:00:00

  • An educational intervention on drug interactions and contraceptive options for epilepsy patients: a pilot randomized controlled trial.

    abstract:OBJECTIVE:This pilot study investigates whether an educational handout could increase short-term information retention about drug interactions between antiepileptic drugs (AEDs) and hormonal contraceptives among female epilepsy patients of reproductive age. STUDY DESIGN:This is a pilot randomized controlled trial of a...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2015.07.008

    authors: Mody SK,Haunschild C,Farala JP,Honerkamp-Smith G,Hur V,Kansal L

    更新日期:2016-01-01 00:00:00

  • The promise and reality of the intrauterine route for hormone delivery for prevention and therapy of gynecological disease.

    abstract:CONTEXT:Progestins delivered by a variety of routes have been demonstrated, in addition to their high contraceptive effect, to have substantial benefits in the treatment of various gynecological disorders, and the intrauterine route has particular efficacy in treating endometrial and myometrial disorders. It should be ...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2006.12.013

    authors: Fraser IS

    更新日期:2007-06-01 00:00:00

  • Flowers of Hibiscus rosa-sinensis, a potential source of contragestative agent: II. Possible mode of action with reference to anti-implantation effect of the benzene extract.

    abstract::Benzene extractives of Hibiscus rosa-sinensis flowers, administered during day 1-4 of gestation, exerted anti-implantation effect without affecting the tubal transport of zygote. On day 4, normal number of blastocyst was present in the uterus but they did not implant. However, as studied by pontamine blue reaction, it...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(85)90021-6

    authors: Pal AK,Bhattacharya K,Kabir SN,Pakrashi A

    更新日期:1985-11-01 00:00:00